A single intradermal injection of IFN-? induces an inflammatory state in both non-lesional psoriatic and healthy skin.
Ontology highlight
ABSTRACT: Psoriasis is a chronic, debilitating, immune-mediated inflammatory skin disease. As IFN-? is involved in many cellular processes, including activation of dendritic cells (DCs), antigen processing and presentation, cell adhesion and trafficking, and cytokine and chemokine production, IFN-?-producing Th1 cells were proposed to be integral to the pathogenesis of psoriasis. Recently, IFN-? was shown to enhance IL-23 and IL-1 production by DCs and subsequently induce Th17 cells, which are important contributors to the inflammatory cascade in psoriatic lesions. To determine whether IFN-? indeed induces the pathways expressed in psoriatic lesions, a single intradermal injection of IFN-? was administered to an area of clinically normal, non-lesional (NL) skin of psoriasis patients and biopsies were collected 24 hours later. Although there were no visible changes in the skin, IFN-? induced many molecular and histological features characteristic of psoriatic lesions. IFN-? increased a number of differentially expressed genes in the skin, including many chemokines concomitant with an influx of T cells and inflammatory DCs. Furthermore, inflammatory DC products tumor necrosis factor (TNF), inducible nitric oxide synthase, IL-23, and TNF-related apoptosis-inducing ligand were present in IFN-?-treated skin. Thus, IFN-?, which is significantly elevated in NL skin compared with healthy skin, appears to be a key pathogenic cytokine that can induce many features of the inflammatory cascade of psoriasis.
SUBMITTER: Johnson-Huang LM
PROVIDER: S-EPMC3305841 | biostudies-literature | 2012 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA